{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T17:27:38Z","timestamp":1788197258727,"version":"build-2803163510"},"reference-count":13,"publisher":"Elsevier BV","issue":"15-16","license":[{"start":{"date-parts":[[2004,5,1]],"date-time":"2004-05-01T00:00:00Z","timestamp":1083369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2004,5]]},"DOI":"10.1016\/j.vaccine.2003.11.051","type":"journal-article","created":{"date-parts":[[2004,1,6]],"date-time":"2004-01-06T05:49:09Z","timestamp":1073368149000},"page":"1836-1841","source":"Crossref","is-referenced-by-count":21,"title":["Thiomersal in vaccines: a regulatory perspective"],"prefix":"10.1016","volume":"22","author":[{"given":"I","family":"Knezevic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Griffiths","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Reigel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Dobbelaer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2003.11.051_BIB1","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1001\/jama.282.18.1763","article-title":"Limiting infant exposure to thimerosal in vaccines and other sources of mercury","volume":"282","author":"Halsey","year":"1999","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.vaccine.2003.11.051_BIB2","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/S0140-6736(05)74714-0","article-title":"Thiomersal in vaccines","volume":"355","author":"Clements","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2003.11.051_BIB3","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1067\/mpd.2000.106797","article-title":"Mercury, infant neurodevelopment, and vaccination","volume":"136","author":"Pless","year":"2000","journal-title":"J. Pediatr."},{"key":"10.1016\/j.vaccine.2003.11.051_BIB4","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1067\/mpd.2000.105133","article-title":"Iatrogenic exposure to mercury after hepatitis B vaccination in preterm infants","volume":"136","author":"Stajich","year":"2000","journal-title":"J. Pediatr."},{"key":"10.1016\/j.vaccine.2003.11.051_BIB5","unstructured":"WHO. Thiomersal as a vaccine preservative. Wkly Epidemiol Rec 2000;75:12\u20136."},{"key":"10.1016\/j.vaccine.2003.11.051_BIB6","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1542\/peds.107.5.1147","article-title":"An assessment of thimerosal use in childhood vaccines","volume":"107","author":"Ball","year":"2001","journal-title":"Pediatric"},{"key":"10.1016\/j.vaccine.2003.11.051_BIB7","unstructured":"WHO Policy Statement: the use of opened multi-dose vials of vaccine in subsequent immunization sessions. 2000. WHO\/V&B\/00.09."},{"key":"10.1016\/j.vaccine.2003.11.051_BIB8","unstructured":"WHO. Vaccines and biologicals: recommendations from the Strategic Advisory Group of Experts. Wkly Epidemiol Rec 2002;77:306."},{"key":"10.1016\/j.vaccine.2003.11.051_BIB9","unstructured":"WHO. Safety of thiomersal. Global Advisory Committee on Vaccine Safety. Wkly Epidemiol Rec 2002;77:390."},{"key":"10.1016\/j.vaccine.2003.11.051_BIB10","unstructured":"CPMP\/BWP\/2517\/00: points to consider on the reduction, elimination or substitution of thiomersal in vaccines. May 2001."},{"key":"10.1016\/j.vaccine.2003.11.051_BIB11","unstructured":"European Commission Regulations No. 541\/95, 542\/95, 1146\/98 and 1069\/98."},{"key":"10.1016\/j.vaccine.2003.11.051_BIB12","unstructured":"Modifica della composizione di medicinali constituti da vaccini monodose iniettabili contenenti mertiolato o altri composti organomercuriali come conservanti o come residui nel processo di fabbricazione. Gazzetta Ufficiale della Repubblica Italiana, serie generale, no. 66 del 19 Marzo 2002. Ministero della salute, Decreto 13 Novembre 2001."},{"key":"10.1016\/j.vaccine.2003.11.051_BIB13","unstructured":"The Drugs & Cosmetic Act. 1940 and rules thereunder (official publication of Government of India)."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X03008545?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X03008545?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,15]],"date-time":"2019-02-15T13:53:21Z","timestamp":1550238801000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X03008545"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,5]]},"references-count":13,"journal-issue":{"issue":"15-16","published-print":{"date-parts":[[2004,5]]}},"alternative-id":["S0264410X03008545"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2003.11.051","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2004,5]]}}}